This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
£0.01011
Share price
-33.50%
Change (1 day)
-98.94%
Change (1 year)
Categories
Athersys (ATHX) - Net assets
Net assets on the balance sheet as of September 2023 : -£27.26 Million
According to Athersys's latest financial reports the company has -£27.26 Million in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Athersys - Net assets on balance sheet (from 2005 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-£19.72 Million | -262.57% |
| 2021-12-31 | $£12.12 M | -47.29% |
| 2020-12-31 | $£23 M | 29.65% |
| 2019-12-31 | $£17.74 M | -47.75% |
| 2018-12-31 | $£33.96 M | 96.38% |
| 2017-12-31 | $£17.29 M | 90.88% |
| 2016-12-31 | $£9.06 M | -31.92% |
| 2015-12-31 | $£13.3 M | -0.83% |
| 2014-12-31 | $£13.42 M | 11.69% |
| 2013-12-31 | $£12.01 M | -4.08% |
| 2012-12-31 | $£12.52 M | 166.79% |
| 2011-12-31 | $£4.69 M | -19.51% |
| 2010-12-31 | $£5.83 M | -50.21% |
| 2009-12-31 | $£11.71 M | -45.6% |
| 2008-12-31 | $£21.53 M | -10.18% |
| 2007-12-31 | $£23.97 M | -9190509.22% |
| 2006-12-31 | $-£0.01 Million | -144.99% |
| 2005-12-31 | $£0 M | 11.33% |
| 2004-12-31 | $£0 M | -99.99% |
| 2003-12-31 | $£8.35 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | £4.64 B | -17,154.54% | 🇺🇸 USA |
 Pfizer PFE | £67.86 B | -249,136.96% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | £13.06 B | -48,040.65% | 🇺🇸 USA |
 Moderna
MRNA | £7.53 B | -27,757.65% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £58.48 B | -214,714.64% | 🇺🇸 USA |
 United States Lime & Minerals USLM | £0.39 B | -1,562.31% | 🇺🇸 USA |
 Merck MRK | £36.24 B | -133,085.30% | 🇺🇸 USA |
 Sanofi SNY | £60.28 B | -221,317.20% | 🇫🇷 France |